Dawn Aerospace Begins Taking Orders for Aurora Spaceplane: A Breakthrough Rocket-Powered Aircraft
Article content
Article content
ŌTAUTAHI CHRISTCHURCH, New Zealand — Dawn Aerospace today announced that its Aurora spaceplane is now available for purchase, with first deliveries expected in 2027. This marks a historic milestone: the first time a space-capable vehicle – designed to fly beyond the Kármán line (100 km – 328,000 ft) – has been offered for direct sale to customers.
Article content
Aurora is set to become the fastest and highest-flying aircraft ever to take off from a conventional runway, blending the extreme performance of rocket propulsion with the reusability and operational simplicity of traditional aviation. This breakthrough enables high-frequency, low-cost access to both high-altitudes and space.
Article content
Aurora introduces a business model akin to commercial airlines, where operators can purchase aircraft and deliver services independently of the manufacturer. Dawn's suborbital spaceplane is engineered for high-frequency operations from traditional airports and spaceports worldwide. Capable of horizontal takeoff and landing, rapid refueling, and multiple flights per day, Aurora offers aircraft-like simplicity, cost-efficiency, and flexibility – enabling local operators to access high-altitudes and space from local runways on demand.
Article content
'For the first time, customers have the opportunity to own an aircraft capable of reaching the edge of space,' said Stefan Powell, CEO of Dawn Aerospace. 'Aurora is a game-changing platform for governments, spaceports, and new spaceplane operators to access extreme altitudes and deliver vital services and programs. It's been over a century since commercial airlines began—now it's time to launch the first spaceline.'
Article content
Aurora enables a new class of missions across defense, signals intelligence, surveillance, hypersonics, maritime patrol, and atmospheric research. It provides microgravity access for the semiconductor and life sciences industries, making it a powerful platform for advancing scientific discovery and national security.
Article content
LIFE SCIENCES: Investigate cellular biology, regenerative medicine, and space health in microgravity conditions.
SEMICONDUCTOR TECHNOLOGY: Test next-gen chips and materials under near-space radiation and thermal extremes.
DEFENSE APPLICATIONS: Validate communications and sensing payloads in high-altitude environments.
Article content
In November 2024, on the 57th flight of Aurora, it reached supersonic speeds, Mach 1.12, and climbed to 82,500 feet / 25.1 km. In doing so, Aurora set a record for the fastest climb from runway to above 20km, breaking a nearly 50-year-old record previously held by the modified F-15 Streak Eagle.
Article content
AURORA SPACEPLANE – KEY SPECIFICATIONS
Article content
Dawn Aerospace is now coordinating inaugural deliveries of Aurora with early adopters across research, commercial, and government sectors.
Article content
Dawn Aerospace is developing the fastest and highest-flying aircraft ever to take off from a runway, combining the extreme performance of rocket propulsion with the reusability of conventional airplanes to enable high-frequency, low-cost access to high-altitudes and space.
Article content
Dawn's remotely piloted aircraft are certified under New Zealand's CAA Part 102 and the New Zealand Space Agency's High-Altitude License, allowing flight from the ground to beyond 60,000 feet—well above conventional airspace limits.
Article content
Dawn's founders recognized the potential of applying aviation-style operations to spaceflight —delivering routine, runway-based access to space with rocket-powered aircraft. In addition to its spaceplane program, Dawn Aerospace is a leading provider of propulsion systems for satellite developers, with its technology currently on 25 operational satellites.
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
2 hours ago
- CTV News
Fighting fire with floats: The Fire Boss aircraft
Winnipeg Watch Dave Frisch, of Fire Boss Technology, explains how Canada can fight fires faster and cheaper with the nimble Fire Boss aircraft.
National Post
9 hours ago
- National Post
SES Announces Appointment of New CFO
Article content Elisabeth Pataki, a progressive finance executive with over 20 years of experience at Article content SES's Leadership Team as new CFO Article content LUXEMBOURG — SES today announced its Board of Directors has appointed Elisabeth (Lisa) Pataki as Chief Financial Officer (CFO), effective 16 June 2025. Lisa is a progressive finance executive with over 20 years of experience at various publicly listed multi-national aerospace and defence companies with strong background in company transformation and investment strategies. She will succeed Sandeep Jalan who has been SES's CFO since May 2020. Article content The SES Board acknowledges Sandeep's contribution to SES and wishes him success in future endeavours. Lisa will work closely with Sandeep to ensure a smooth handover before he leaves on 31 July 2025. Article content 'I would like to thank Sandeep for his steadfast leadership over the last five years where he has driven continuous execution improvement and transformation while strengthening the company's balance sheet with a competitive cost of capital and delivering healthy cash returns to shareholders,' said Adel Al-Saleh, CEO of SES. 'We are pleased to welcome Lisa as our new CFO. Lisa has extensive experience in the aerospace and defence ecosystem and has completed several successful M&A finance integrations. Moreover, her ability to develop financial strategies that prioritise operational focus, efficiency, and profitable investments will strengthen SES's Leadership Team, helping SES achieve our mission of being a leading satellite player.' Article content 'I would like to thank everyone at SES for their outstanding teamwork,' said Sandeep, CFO of SES. 'I am proud of the strides we have made during the past years, and I will continue to cheer SES's progress in the industry.' Article content Incoming CFO Lisa said, 'I look forward to stepping into this new position and working with everyone at SES to jointly deliver an exciting future for the years to come.' Article content Lisa joins SES from Aerojet Rocketdyne, an L3Harris Company, where she helped expand profitability through streamlining operations and prioritising capital investments for long-term growth. As Group CFO for the Comet Group from 2020-2023, she drove EBITDA margin expansion of over 5 percentage points. In her 10-year progressive career (2005-2015) across RTX Corporation (formerly Raytheon Technologies Corporation), she held multiple finance roles and led the financial integration of Applied Signal Technologies, one of Raytheon's largest acquisitions in 2011. Article content Twitter Article content | Article content Facebook Article content | Article content YouTube Article content | Article content LinkedIn Article content | Article content Instagram Article content Article content Article content Visit the Media Gallery > Article content About SES Article content SES has a bold vision to deliver amazing experiences everywhere on Earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a provider of global content and connectivity solutions, SES owns and operates a geosynchronous earth orbit (GEO) fleet and medium earth orbit (MEO) constellation of satellites, offering a combination of global coverage and high-performance services. By using its intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners around the world. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: Article content Article content Contacts Article content
Cision Canada
a day ago
- Cision Canada
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22
NASDAQ| TSX: ACB Canada's Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market EDMONTON, AB, June 5, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available through the company's subsidiary, MedReleaf Australia. With the same consistent quality and reliable supply, this new 22% THC potency creates a greater range of treatment options available to prescribers. "Expanding our portfolio in the value segment in Australia reinforces our commitment to meet increasingly diversified patient needs with accessible, high-quality medical cannabis options," said Andre Jerome, Executive Vice President of Global Business Development at Aurora. "As a global leader in medical cannabis, we're proud to offer a diverse range of products that reflect both local demand and our dedication to innovation worldwide." IndiMed remains one of the most prescribed medical cannabis brands for patients in Australia. The two new cultivars available include: IndiMed TEMPO 22 | Lemon Laser – Sativa, 22% THC, <1% CBD, Dried Cannabis (15g) IndiMed TEMPO 22 | Pickled Petrol – Indica, 22% THC, <1% CBD, Dried Cannabis (15g) Aurora's continued focus on international growth and deep commitment to providing patients with innovative products and expanded access enables the company to maintain its global leadership position. MedReleaf Australia, a wholly owned subsidiary of Aurora, is committed to quality and proudly meeting all TGA-GMP standards. For further information about the company's offerings, doctors and health care professionals can contact MedReleaf Australia's clinical support team or visit their website: About Aurora Cannabis Inc. Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Contact For Investors: ICR, Inc. | [email protected] Forward Looking Information This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law (" forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding: the expansion of the Company's medical cannabis offerings in Australia and the availability of specific products; the Company's commitment to innovation, quality and expanded access; the Company's continued focus on international growth; and the Company's global leadership position. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at and filed with and available on the SEC's website at The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
